Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Carfilzomib
Related studies linked through entity extraction aliases.
Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1